IGHE and asthma: When the analyses were repeated for the highest 10% of ARI notifications, the effects were less pronounced, but still significant for hay fever, inhalant sensitization and total IgE for months 3–6 and additionally for total sensitization for month 6–9 and for asthma, eczema and indoor allergen sensitization for the third trimester (data not shown).